Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1999 Jun 22

PMID 10377195

Citations 35

Authors

H E Broxmeyer

S Cooper

G Hangoc

J L Gao

P M Murphy

Affiliations

Soon will be listed here.

Abstract

Macrophage inflammatory protein (MIP)-1alpha, a CC chemokine, enhances proliferation of mature subsets of myeloid progenitor cells (MPCs), suppresses proliferation of immature MPCs, and mobilizes mature and immature MPCs to the blood. MIP-1alpha binds at least three chemokine receptors. To determine if CCR1 was dominantly mediating the above activities of MIP-1alpha, CCR1-deficient (-/-) mice, produced by targeted gene disruption, were used. MIP-1alpha enhanced colony formation of marrow granulocyte/macrophage colony-forming units (CFU-GM), responsive to stimulation by granulocyte/macrophage colony-stimulating factor (GM-CSF), and CFU-M, responsive to stimulation by M-CSF, from littermate control CCR1(+/+) but not CCR1(-/-) mice. Moreover, MIP-1alpha did not mobilize MPCs to the blood or synergize with G-CSF in this effect in CCR1(-/-) mice. However, CCR1(-/-) mice were increased in sensitivity to MPC mobilizing effects of G-CSF. Multi-growth factor-stimulated MPCs in CCR1(-/-) and CCR1(+/+) marrow were equally sensitive to inhibition by MIP-1alpha. These results implicate CCR1 as a dominant receptor for MIP-1alpha enhancement of proliferation of lineage-committed MPCs and for mobilization of MPCs to the blood. CCR1 is not a dominant receptor for MIP-1alpha suppression of MPC proliferation, but it does negatively impact G-CSF-induced MPC mobilization.

Citing Articles

Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data.

Wu W, Chen Z, Wen H, Zhang H Front Genet. 2024; 15:1431684.

PMID: 39175755 PMC: 11338847. DOI: 10.3389/fgene.2024.1431684.

Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells.

Pensato V, Laginestra M, Falvo P, Orecchioni S, Talarico G, De Marchi E Stem Cells. 2023; 42(1):42-54.

PMID: 37798139 PMC: 10787278. DOI: 10.1093/stmcls/sxad075.

Panhematopoietic RNA barcoding enables kinetic measurements of nucleate and anucleate lineages and the activation of myeloid clones following acute platelet depletion.

Wojtowicz E, Mistry J, Uzun V, Hellmich C, Scoones A, Chin D Genome Biol. 2023; 24(1):152.

PMID: 37370129 PMC: 10294477. DOI: 10.1186/s13059-023-02976-z.

The influence of apical periodontitis on circulatory inflammatory mediators in peripheral blood: A prospective case-control study.

Georgiou A, Twisk J, Crielaard W, Ouwerling P, Schoneveld A, van der Waal S Int Endod J. 2022; 56(2):130-145.

PMID: 36284462 PMC: 10098678. DOI: 10.1111/iej.13854.

Regulation of emergency granulopoiesis during infection.

Paudel S, Ghimire L, Jin L, Jeansonne D, Jeyaseelan S Front Immunol. 2022; 13:961601.

PMID: 36148240 PMC: 9485265. DOI: 10.3389/fimmu.2022.961601.

References

Broxmeyer H, Sherry B, Lu L, Cooper S, Carow C, Wolpe S . Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells. J Exp Med. 1989; 170(5):1583-94. PMC: 2189508. DOI: 10.1084/jem.170.5.1583. View

Reid S, Ritchie A, Boring L, Gosling J, Cooper S, Hangoc G . Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood. 1999; 93(5):1524-33. View

Broxmeyer H, Sherry B, Lu L, Cooper S, Oh K, Kwon B . Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 1990; 76(6):1110-6. View

Dunlop D, Wright E, Lorimore S, Graham G, Holyoake T, Kerr D . Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. Blood. 1992; 79(9):2221-5. View

LORD B, Dexter T, Clements J, Hunter M, Gearing A . Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood. 1992; 79(10):2605-9. View

Clements J, Craig S, Gearing A, Hunter M, Heyworth C, Dexter T . Biological and structural properties of MIP-1 alpha expressed in yeast. Cytokine. 1992; 4(1):76-82. DOI: 10.1016/1043-4666(92)90040-x. View

Maze R, Sherry B, Kwon B, Cerami A, Broxmeyer H . Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J Immunol. 1992; 149(3):1004-9. View

Broxmeyer H, Sherry B, Cooper S, Lu L, Maze R, Beckmann M . Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol. 1993; 150(8 Pt 1):3448-58. View

Lu L, Xiao M, Grigsby S, Wang W, Wu B, Shen R . Comparative effects of suppressive cytokines on isolated single CD34(3+) stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol. 1993; 21(11):1442-6. View

10.

Keller J, Bartelmez S, Sitnicka E, Ruscetti F, Ortiz M, Gooya J . Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Blood. 1994; 84(7):2175-81. View

11.

LORD B, Woolford L, Wood L, Czaplewski L, McCourt M, Hunter M . Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha. Blood. 1995; 85(12):3412-5. View

12.

Murphy P . Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 1996; 7(1):47-64. DOI: 10.1016/1359-6101(96)00009-3. View

13.

Broxmeyer H, Cooper S, Cacalano G, Hague N, Bailish E, Moore M . Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J Exp Med. 1996; 184(5):1825-32. PMC: 2192871. DOI: 10.1084/jem.184.5.1825. View

14.

Van Ranst P, Snoeck H, Lardon F, Lenjou M, Nijs G, Weekx S . TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. Exp Hematol. 1996; 24(13):1509-15. View

15.

Hromas R, Gray P, Chantry D, Godiska R, Krathwohl M, Fife K . Cloning and characterization of exodus, a novel beta-chemokine. Blood. 1997; 89(9):3315-22. View

16.

Gao J, Wynn T, Chang Y, Lee E, Broxmeyer H, Cooper S . Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med. 1997; 185(11):1959-68. PMC: 2196337. DOI: 10.1084/jem.185.11.1959. View

17.

Su S, Mukaida N, Wang J, Zhang Y, Takami A, Nakao S . Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1. Blood. 1997; 90(2):605-11. View

18.

Rollins B . Chemokines. Blood. 1997; 90(3):909-28. View

19.

Liu F, Poursine-Laurent J, Link D . The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood. 1997; 90(7):2522-8. View

20.

Boring L, Gosling J, Chensue S, Kunkel S, Farese Jr R, Broxmeyer H . Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 1997; 100(10):2552-61. PMC: 508456. DOI: 10.1172/JCI119798. View